Placebo-controlled trial of moclobemide in social phobia
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Moclobemide, a reversible inhibitor of monoamine oxidase A, previously has been reported to have efficacy in the treatment of social phobia. Method: Seventy-seven non-responders to one week of single-blind placebo were randomly assigned to moclobemide or placebo for eight weeks of double-blind treatment. Outcome was assessed by independent evaluator, treating psychiatrist and self-ratings. After eight weeks, patients who were at least minimally improved continued treatment for a further eight weeks. Results: Intention-to-treat sample response rates at week 8 were 7/40 (17.5%) for the moclobemide group and 5/37 (13.5%) for placebo (NS). Moclobemide was significantly superior to placebo on 2 of 10 primary outcome measures. Moclobemide was well tolerated. Conclusions: Moclobemide may have efficacy in the treatment of social phobia, but absence of significant differences on most primary outcome measures and small effect sizes for all outcome measures suggest that the magnitude of its clinical effect is small.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Self-citationBrief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Self-citationCognitive-Behavioral and Pharmacological Treatments of Social Phobia: A Controlled Study
Gelernter, C. S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340070009 · Cited by 404
Research works printed but not linked: 29
- 10.1007/BF01173521 · DOI · Paper page
- 10.1001/archpsyc.1974.01760150035005 · DOI · Paper page
- 10.1037/0022-006X.62.2.350 · DOI · Paper page
- 1997, Moclobemide in social phobia. A double-blind, placebo controlled clinical study, European Archives of Psychiatry and Clinical Neuroscience, 24, 71
- Korn, 1988, Tyramine pressor effect in man: studies with moclobemide, a novel reversible monoamine oxidase inhibitor, Journal of Neural Transmission, suppl. 26, 57
- Derogatis, 1983, SCL-90-R. Administration, Scoring, and Procedures Manual
- 10.1097/00004714-199708000-00003 · DOI · Paper page
- 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- 10.1097/00004714-199312000-00008 · DOI · Paper page
- Guy, 1976, ECDEU Assessment Manual for Psychopharmacology, 217
- Sheehan, 1983, The Anxiety Disease, 148
- 1987, Diagnostic and Statistical Manual of Mental Disorders
- Schneier, 1994, Functional impairment in social phobia, Journal of Clinical Psychiatry, 55, 322
- Liebowitz, 1988, Pharmacotherapy of social phobia: an interim report of a placebo controlled comparison of phenelzine and atenolol, Journal of Clinical Psychiatry, 49, 252
- Spitzer, 1990, Structural Clinical Interview of DSM–III–R Axis II Disorders (SCID–II)
- 10.1097/00004850-199606003-00014 · DOI · Paper page
- Johnson, 1926, Tests of certain linear hypotheses and their application to some educational problems, Stat Res Memoirs, 1, 57
- 10.1016/0165-0327(94)90015-9 · DOI
- 10.1097/00004714-199708000-00002 · DOI · Paper page
- 10.1136/jnnp.23.1.56 · DOI · Paper page
- Waldmeier, 1967, Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain), Journal of Neural Transmission, suppl. 23, 55
- 10.1037/h0027806 · DOI · Paper page
- 10.1097/00002826-199417001-00010 · DOI
- 10.1192/bjp.161.3.353 · DOI · Paper page
- 10.1111/j.1600-0447.1995.tb09596.x · DOI · Paper page
- 10.1016/0924-977X(92)90032-4 · DOI
- Spitzer, 1987, Structured Clinical Interview of DSM–III–R (SCID–I)
- 10.1007/BF02244762 · DOI · Paper page
- Waldmeier, 1993, Brofaromine: A monoamine oxidase-A and serotonin uptake inhibitor, Clinical Neuropharmacology, 16, S19
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Psychometric properties of the Liebowitz Social Anxiety Scale
HEIMBERG, R. G., HORNER, K. J., JUSTER, H. R., SAFREN, S. A., BROWN, E. J., SCHNEIER, F. R., & LIEBOWITZ, M. R. (1999) · Psychological Medicine · doi:10.1017/s0033291798007879 · Cited by 968
“…group treatment conducted in Albany (N¯ 86) (Brown et al. 1995; Juster et al. 1995; Leung & Heimberg, 1996) (total N¯ 143) ; (3) the New York site of the collaborative study described above (N¯ 73) ; and (4) a study comparing moclobemide and pill placebo (N¯ 75) (Schneier et al. 1998).”
BackgroundSelf-citationBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Psychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Fedoroff, I. C., & Taylor, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00011 · Cited by 396
Evaluation of the Clinical Global Impression Scale among individuals with social anxiety disorder
ZAIDER, T. I., HEIMBERG, R. G., FRESCO, D. M., SCHNEIER, F. R., & LIEBOWITZ, M. R. (2003) · Psychological Medicine · doi:10.1017/s0033291703007414 · Cited by 286
Self-citation
Metadata
- Authors
- Schneier, F. R., Goetz, D., Campeas, R., Marshall, R., Fallon, B., & Liebowitz, M. R.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1998-01
- Volume
- 172
- Issue
- 1
- Pages
- 70-77
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2170551345
- Cited by
- 139
- References
- 5
- FWCI
- 27.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.